SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-027130
Filing Date
2024-07-12
Accepted
2024-07-12 17:20:28
Documents
8

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 6003743
2 forms-4a_001.jpg GRAPHIC 9814
3 forms-4a_002.jpg GRAPHIC 38231
4 forms-4a_003.jpg GRAPHIC 11875
5 forms-4a_004.jpg GRAPHIC 25023
6 annexg_001.jpg GRAPHIC 371478
7 annexg_002.jpg GRAPHIC 398762
8 annexg_003.jpg GRAPHIC 306021
  Complete submission text file 0001493152-24-027130.txt   7604884
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-275506 | Film No.: 241115289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)